ID

33517

Descrizione

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Keywords

versioni (3)
  1. 11/12/18 11/12/18 -
  2. 05/06/19 05/06/19 -
  3. 06/06/19 06/06/19 - Sarah Riepenhausen
Titolare del copyright

GSK group of companies

Caricato su

11 dicembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)

Inglese

Visit 1: Eligibility Criteria

1 moduli  
Administrative data
Descrizione

Administrative data

Protocol Number
Descrizione

Protocol Number

Tipo di dati

integer

Subject Number
Descrizione

Subject Number

Tipo di dati

integer

Visit
Descrizione

Visit

Tipo di dati

text

Eligibility Check
Descrizione

Eligibility Check

Did the subject meet all the entry criteria?
Descrizione

entry criteria met?

Tipo di dati

boolean

If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
Descrizione

If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.

Tipo di dati

text

Inclusion Criteria
Descrizione

Inclusion Criteria

Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
Descrizione

Tick all the boxes corresponding to any of the inclusion criteria the subject failed.

Tipo di dati

integer

Exclusion Criteria
Descrizione

Exclusion Criteria

Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
Descrizione

Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

Visit 1: Eligibility Criteria

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative data
Protocol Number
Item
Protocol Number
integer
Subject Number
Item
Subject Number
integer
Item
Visit
text
Visit
Code List
Visit
CL Item
Visit 1, Study month 21 (21 months post dose 1 in Malaria-026) (1)
Item Group
Eligibility Check
entry criteria met?
Item
Did the subject meet all the entry criteria?
boolean
If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
Item
If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
text
Item Group
Inclusion Criteria
Item
Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
integer
Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
Code List
Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
CL Item
Completion of Visit 7, Month 21 of Malaria-026. (1)
CL Item
Written informed consent obtained from the parent(s) or guardian(s) of the subject. (2)
Item Group
Exclusion Criteria
Item
Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
text
Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
Code List
Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
CL Item
Planned use of any investigational or non-registered drug or vaccine during the study period. (1)
CL Item
Simultaneous participation in any other clinical trial. (2)
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial